{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:52:48Z","timestamp":1783468368371,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00393-019-0623-x","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T14:03:28Z","timestamp":1554127408000},"page":"322-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hypereosinophiles Syndrom und\u00a0weitere rheumatische Erkrankungen mit Hypereosinophilie","Hypereosinophilic syndrome and other rheumatic diseases with hypereosinophilia"],"prefix":"10.1007","volume":"78","author":[{"given":"J. H.","family":"Schirmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. F.","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,1]]},"reference":[{"key":"623_CR1","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1002\/art.30514","volume":"63","author":"JA Allen","year":"2011","unstructured":"Allen JA, Peterson A, Sufit R et al (2011) Post-epidemic eosinophilia-myalgia syndrome associated with L\u2011tryptophan. Arthritis Rheum 63:3633\u20133639. \n                    https:\/\/doi.org\/10.1002\/art.30514","journal-title":"Arthritis Rheum"},{"key":"623_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJM199008093230601","volume":"323","author":"EA Belongia","year":"1990","unstructured":"Belongia EA, Hedberg CW, Gleich GJ et al (1990) An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N\u00a0Engl J Med 323:357\u2013365. \n                    https:\/\/doi.org\/10.1056\/NEJM199008093230601","journal-title":"N Engl J Med"},{"key":"623_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/ejh.12842","volume":"98","author":"MN Carruthers","year":"2017","unstructured":"Carruthers MN, Park S, Slack GW et al (2017) IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: a comparative case series. Eur J Haematol 98:378\u2013387. \n                    https:\/\/doi.org\/10.1111\/ejh.12842","journal-title":"Eur J Haematol"},{"key":"623_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A et al (2015) Rituximab for IgG4-related disease: a\u00a0prospective, open-label trial. Ann Rheum Dis 74:1171\u20131177. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2014-206605","journal-title":"Ann Rheum Dis"},{"key":"623_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-197501000-00001","volume":"54","author":"MJ Chusid","year":"1975","unstructured":"Chusid MJ, Dale DC, West BC, Wolff SM (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54:1\u201327","journal-title":"Medicine (Baltimore)"},{"key":"623_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autrev.2016.09.018","volume":"16","author":"V Cottin","year":"2017","unstructured":"Cottin V, Bel E, Bottero P et al (2017) Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d\u2019Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Autoimmun Rev 16:1\u20139. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2016.09.018","journal-title":"Autoimmun Rev"},{"key":"623_CR7","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181\u20131192. \n                    https:\/\/doi.org\/10.1038\/modpathol.2012.72","journal-title":"Mod. Pathol."},{"key":"623_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","volume":"26","author":"M Groh","year":"2015","unstructured":"Groh M, Pagnoux C, Baldini C et al (2015) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med 26:545\u2013553. \n                    https:\/\/doi.org\/10.1016\/j.ejim.2015.04.022","journal-title":"Eur J Intern Med"},{"key":"623_CR9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJM199003293221301","volume":"322","author":"PA Hertzman","year":"1990","unstructured":"Hertzman PA, Blevins WL, Mayer J et al (1990) Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N\u00a0Engl J Med 322:869\u2013873. \n                    https:\/\/doi.org\/10.1056\/NEJM199003293221301","journal-title":"N Engl J Med"},{"key":"623_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/clc.4960170902","volume":"17","author":"TN James","year":"1994","unstructured":"James TN (1994) The toxic oil syndrome. Clin Cardiol 17:463\u2013470","journal-title":"Clin Cardiol"},{"key":"623_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et\u00a0al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1\u201311. \n                    https:\/\/doi.org\/10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"623_CR12","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL et al (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67:1688\u20131699. \n                    https:\/\/doi.org\/10.1002\/art.39132","journal-title":"Arthritis. Rheumatol."},{"key":"623_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1182\/blood-2014-11-551614","volume":"126","author":"AD Klion","year":"2015","unstructured":"Klion AD (2015) How I treat hypereosinophilic syndromes. Blood 126:1069\u20131077. \n                    https:\/\/doi.org\/10.1182\/blood-2014-11-551614","journal-title":"Blood"},{"key":"623_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.autrev.2016.11.001","volume":"16","author":"G Lef\u00e8vre","year":"2017","unstructured":"Lef\u00e8vre G, Ackermann F, Kahn J\u2011E (2017) Hypereosinophilia with asthma and systemic (non-vasculitic) manifestations: eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome? Autoimmun Rev 16:208\u2013209. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2016.11.001","journal-title":"Autoimmun Rev"},{"key":"623_CR15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/art.1780330806","volume":"33","author":"AT Masi","year":"1990","unstructured":"Masi AT, Hunder GG, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094\u20131100","journal-title":"Arthritis Rheum"},{"key":"623_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40257-017-0269-x","volume":"18","author":"JS Mertens","year":"2017","unstructured":"Mertens JS, Seyger MMB, Thurlings RM et\u00a0al (2017) Morphea and eosinophilic fasciitis: an update. Am J Clin Dermatol 18:491\u2013512. \n                    https:\/\/doi.org\/10.1007\/s40257-017-0269-x","journal-title":"Am J Clin Dermatol"},{"key":"623_CR17","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","volume":"124","author":"PU Ogbogu","year":"2009","unstructured":"Ogbogu PU, Bochner BS, Butterfield JH et\u00a0al (2009) Hypereosinophilic syndrome: a\u00a0multicenter, retrospective analysis of clinical characteristics and response to therapy. J\u00a0Allergy Clin Immunol 124:1319\u20131325.e3. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2009.09.022","journal-title":"J Allergy Clin Immunol"},{"key":"623_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/BOR.0000000000000014","volume":"26","author":"WF Pendergraft","year":"2014","unstructured":"Pendergraft WF, Niles JL (2014) Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol 26:42\u201349. \n                    https:\/\/doi.org\/10.1097\/BOR.0000000000000014","journal-title":"Curr Opin Rheumatol"},{"key":"623_CR19","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/art.40168","volume":"69","author":"CA Perugino","year":"2017","unstructured":"Perugino CA, Mattoo H, Mahajan VS et al (2017) Emerging treatment models in rheumatology: IgG4-related disease: insights into human immunology and targeted therapies. Arthritis Rheumatol 69:1722\u20131732. \n                    https:\/\/doi.org\/10.1002\/art.40168","journal-title":"Arthritis Rheumatol"},{"key":"623_CR20","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","volume":"129","author":"A Reiter","year":"2017","unstructured":"Reiter A, Gotlib J (2017) Myeloid neoplasms with eosinophilia. Blood 129:704\u2013714. \n                    https:\/\/doi.org\/10.1182\/blood-2016-10-695973","journal-title":"Blood"},{"key":"623_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.rmcr.2017.12.012","volume":"23","author":"F Reyes","year":"2018","unstructured":"Reyes F, Vaitkus V, Al-Ajam M (2018) A case of cocaine-induced eosinophilic pneumonia: case report and review of the literature. Respir Med Case Rep 23:98\u2013102. \n                    https:\/\/doi.org\/10.1016\/j.rmcr.2017.12.012","journal-title":"Respir Med Case Rep"},{"key":"623_CR22","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa070812","volume":"358","author":"ME Rothenberg","year":"2008","unstructured":"Rothenberg ME, Klion AD, Roufosse FE et\u00a0al (2008) Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N\u00a0Engl J Med 358:1215\u20131228. \n                    https:\/\/doi.org\/10.1056\/NEJMoa070812","journal-title":"N Engl J Med"},{"key":"623_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fmed.2018.00049","volume":"5","author":"F Roufosse","year":"2018","unstructured":"Roufosse F (2018) Targeting the Interleukin-5 pathway for treatment of Eosinophilic conditions other than asthma. Front Med 5:49. \n                    https:\/\/doi.org\/10.3389\/fmed.2018.00049","journal-title":"Front Med"},{"key":"623_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1750-1172-2-37","volume":"2","author":"FE Roufosse","year":"2007","unstructured":"Roufosse FE, Goldman M, Cogan E (2007) Hypereosinophilic syndromes. Orphanet J Rare Dis 2:37. \n                    https:\/\/doi.org\/10.1186\/1750-1172-2-37","journal-title":"Orphanet J Rare Dis"},{"key":"623_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00393-017-0394-1","volume":"76","author":"JH Schirmer","year":"2017","unstructured":"Schirmer JH, Aries PM, de Groot K et al (2017) S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis. Z\u00a0Rheumatol 76:77\u2013104. \n                    https:\/\/doi.org\/10.1007\/s00393-017-0394-1","journal-title":"Z Rheumatol"},{"key":"623_CR26","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/NEJM199003293221302","volume":"322","author":"RM Silver","year":"1990","unstructured":"Silver RM, Heyes MP, Maize JC et\u00a0al (1990) Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N\u00a0Engl J Med 322:874\u2013881. \n                    https:\/\/doi.org\/10.1056\/NEJM199003293221302","journal-title":"N Engl J Med"},{"key":"623_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1053\/j.seminhematol.2012.01.002","volume":"49","author":"H-U Simon","year":"2012","unstructured":"Simon H\u2011U, Klion A (2012) Therapeutic approaches to patients with hypereosinophilic syndromes. Semin Hematol 49:160\u2013170. \n                    https:\/\/doi.org\/10.1053\/j.seminhematol.2012.01.002","journal-title":"Semin Hematol"},{"key":"623_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaci.2010.03.042","volume":"126","author":"H-U Simon","year":"2010","unstructured":"Simon H\u2011U, Rothenberg ME, Bochner BS et al (2010) Refining the definition of hypereosinophilic syndrome. J\u00a0Allergy Clin Immunol 126:45\u201349. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2010.03.042","journal-title":"J Allergy Clin Immunol"},{"key":"623_CR29","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/art.34593","volume":"64","author":"JH Stone","year":"2012","unstructured":"Stone JH, Khosroshahi A, Deshpande V et al (2012) Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 64:3061\u20133067. \n                    https:\/\/doi.org\/10.1002\/art.34593","journal-title":"Arthritis Rheum"},{"key":"623_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N\u00a0Engl J Med 366:539\u2013551. \n                    https:\/\/doi.org\/10.1056\/NEJMra1104650","journal-title":"N Engl J Med"},{"key":"623_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/all.12320","volume":"69","author":"DE Torre","year":"2014","unstructured":"Torre DE, Mattoo H, Mahajan VS et al (2014) Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Arerugi 69:269\u2013272. \n                    https:\/\/doi.org\/10.1111\/all.12320","journal-title":"Arerugi"},{"key":"623_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","volume":"130","author":"P Valent","year":"2012","unstructured":"Valent P, Klion AD, Horny H\u2011P et al (2012) Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J\u00a0Allergy Clin Immunol 130:607\u2013612.e9. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2012.02.019","journal-title":"J Allergy Clin Immunol"},{"key":"623_CR33","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Deshpande V, Mattoo H et al (2015) IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol 67:2466\u20132475. \n                    https:\/\/doi.org\/10.1002\/art.39205","journal-title":"Arthritis Rheumatol"},{"key":"623_CR34","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","volume":"376","author":"ME Wechsler","year":"2017","unstructured":"Wechsler ME, Akuthota P, Jayne D et\u00a0al (2017) Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N\u00a0Engl J Med 376:1921\u20131932. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1702079","journal-title":"N Engl J Med"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-019-0623-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-019-0623-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-019-0623-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T23:28:05Z","timestamp":1585610885000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-019-0623-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["623"],"URL":"https:\/\/doi.org\/10.1007\/s00393-019-0623-x","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]},"assertion":[{"value":"1 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.H.\u00a0Schirmer und B.F.\u00a0Hoyer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.  F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}